Skip to main content
Top
Published in: Calcified Tissue International 1/2017

01-07-2017

Histological and Ultrastructural Characterization of Alkaptonuric Tissues

Authors: Lia Millucci, Giulia Bernardini, Adriano Spreafico, Maurizio Orlandini, Daniela Braconi, Marcella Laschi, Michela Geminiani, Pietro Lupetti, Giovanna Giorgetti, Cecilia Viti, Bruno Frediani, Barbara Marzocchi, Annalisa Santucci

Published in: Calcified Tissue International | Issue 1/2017

Login to get access

Abstract

Alkaptonuria (AKU) is a hereditary disorder that results from altered structure and function of homogentisate 1,2 dioxygenase (HGD). This enzyme, predominantly produced by liver and kidney, is responsible for the breakdown of homogentisic acid (HGA), an intermediate in the tyrosine degradation pathway. A deficient HGD activity causes HGA levels to rise systemically. The disease is clinically characterized by homogentisic aciduria, bluish-black discoloration of connective tissues (ochronosis) and joint arthropathy. Additional manifestations are cardiovascular abnormalities, renal, urethral and prostate calculi and scleral and ear involvement. While the radiological aspect of ochronotic spondyloarthropathy is known, there are only few data regarding an exhaustive ultrastructural and histologic study of different tissues in AKU. Moreover, an in-depth analysis of tissues from patients of different ages, having varied symptoms, is currently lacking. A complete microscopic and ultrastructural analysis of different AKU tissues, coming from six differently aged patients, is here presented thus significantly contributing to a more comprehensive knowledge of this ultra-rare pathology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ranganath LR, Milan AM, Hughes AT et al (2016) Suitability of nitisinone in Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis 75:362–367. doi:10.1136/annrheumdis-2014-206033 CrossRefPubMed Ranganath LR, Milan AM, Hughes AT et al (2016) Suitability of nitisinone in Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis 75:362–367. doi:10.​1136/​annrheumdis-2014-206033 CrossRefPubMed
2.
go back to reference Nemethova M, Radvanszky J, Kadasi L et al (2016) Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on ‘black bone disease’ in Italy. Eur J Hum Gene 24:66–72. doi:10.1038/ejhg.2015.60 CrossRef Nemethova M, Radvanszky J, Kadasi L et al (2016) Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on ‘black bone disease’ in Italy. Eur J Hum Gene 24:66–72. doi:10.​1038/​ejhg.​2015.​60 CrossRef
4.
go back to reference Virchow R (1866) Ein fall von allgemeiner ochronose der knorpel und knorpelahnliken theile. Virchow’s Arch Pathol Anat 37:212–219CrossRef Virchow R (1866) Ein fall von allgemeiner ochronose der knorpel und knorpelahnliken theile. Virchow’s Arch Pathol Anat 37:212–219CrossRef
5.
go back to reference Perry MB, Suwannarat P, Furst GP, Gahl WA, Gerber LH (2006) Musculoskeletal findings and disability in alkaptonuria. J Rheumatol 33:2280–2285PubMed Perry MB, Suwannarat P, Furst GP, Gahl WA, Gerber LH (2006) Musculoskeletal findings and disability in alkaptonuria. J Rheumatol 33:2280–2285PubMed
7.
go back to reference Millucci L, Ghezzi L, Paccagnini E et al (2014) Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediat Inflamm 2014:258471. doi:10.1155/2014/258471 CrossRef Millucci L, Ghezzi L, Paccagnini E et al (2014) Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediat Inflamm 2014:258471. doi:10.​1155/​2014/​258471 CrossRef
9.
go back to reference Laschi M, Bernardini G, Dreassi E et al (2016) Inhibition of para-hydroxyphenylpyruvate dioxygenase by analogues of the herbicide nitisinone as a strategy to decrease homogentisic acid levels, the causative agent of Alkaptonuria. Chem Med Chem 11:674–678. doi:10.1002/cmdc.201500578 CrossRefPubMed Laschi M, Bernardini G, Dreassi E et al (2016) Inhibition of para-hydroxyphenylpyruvate dioxygenase by analogues of the herbicide nitisinone as a strategy to decrease homogentisic acid levels, the causative agent of Alkaptonuria. Chem Med Chem 11:674–678. doi:10.​1002/​cmdc.​201500578 CrossRefPubMed
15.
16.
go back to reference Tinti L, Spreafico A, Braconi D et al (2010) Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol 225:84–91. doi:10.1002/jcp.22199 CrossRefPubMed Tinti L, Spreafico A, Braconi D et al (2010) Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol 225:84–91. doi:10.​1002/​jcp.​22199 CrossRefPubMed
18.
20.
go back to reference Helliwell TR, Gallagher JA, Ranganath L (2008) Alkaptonuria–a review of surgical and autopsy pathology. Histopathology 53(5):503–512PubMed Helliwell TR, Gallagher JA, Ranganath L (2008) Alkaptonuria–a review of surgical and autopsy pathology. Histopathology 53(5):503–512PubMed
21.
go back to reference Taylor AM, Wlodarski B, Prior IA et al (2010) Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment. Rheumatology 49(7):1412–1414CrossRefPubMed Taylor AM, Wlodarski B, Prior IA et al (2010) Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment. Rheumatology 49(7):1412–1414CrossRefPubMed
23.
go back to reference Taylor AM, Boyde A, Wilson PJ et al (2011) The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 63:3887–3896. doi:10.1002/art.30606 CrossRefPubMed Taylor AM, Boyde A, Wilson PJ et al (2011) The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 63:3887–3896. doi:10.​1002/​art.​30606 CrossRefPubMed
24.
go back to reference Barton GJ, King SL, Robinson MA et al (2010) Age-related deviation of gait from normality in alkaptonuria. JIMD Rep 24:39–44CrossRef Barton GJ, King SL, Robinson MA et al (2010) Age-related deviation of gait from normality in alkaptonuria. JIMD Rep 24:39–44CrossRef
26.
go back to reference Bae CS, Oh DM, Bae JG et al (2006) Ultrastructural changes of the gemifloxacin on achilles tendon in immature rats: comparison with those of ciproxacin and ofloxacin. Basic Clin Pharmacol Toxicol 98:406–410CrossRefPubMed Bae CS, Oh DM, Bae JG et al (2006) Ultrastructural changes of the gemifloxacin on achilles tendon in immature rats: comparison with those of ciproxacin and ofloxacin. Basic Clin Pharmacol Toxicol 98:406–410CrossRefPubMed
28.
go back to reference Kraus VB (2014) Rare osteoarthritis: ochronosis and Kashin-Beck disease. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 6th edn, Chap. 185. Mosby Elsevier, Philadelphia, pp 1536–1540 Kraus VB (2014) Rare osteoarthritis: ochronosis and Kashin-Beck disease. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 6th edn, Chap. 185. Mosby Elsevier, Philadelphia, pp 1536–1540
30.
go back to reference Ranganath L, Taylor AM, Shenkin A et al (2011) Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers. J Inherit Metab Dis 34(3):723–30. doi:10.1007/s10545-011-9282-z CrossRefPubMed Ranganath L, Taylor AM, Shenkin A et al (2011) Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers. J Inherit Metab Dis 34(3):723–30. doi:10.​1007/​s10545-011-9282-z CrossRefPubMed
31.
go back to reference Taylor AM, Batchelor TJ, Adams VL et al (2011) Ochronosis and calcification in the mediastinal mass of a patient with alkaptonuria. Clin Pathol 64(10):935–6CrossRef Taylor AM, Batchelor TJ, Adams VL et al (2011) Ochronosis and calcification in the mediastinal mass of a patient with alkaptonuria. Clin Pathol 64(10):935–6CrossRef
32.
go back to reference Taylor AM, Boyde A, Davidson JS et al (2012) Identification of trabecular excrescences, novel microanatomical structures, present in bone in osteoarthropathies. Eur Cell Mater 21(23):300–308 (discussion 308-9)CrossRef Taylor AM, Boyde A, Davidson JS et al (2012) Identification of trabecular excrescences, novel microanatomical structures, present in bone in osteoarthropathies. Eur Cell Mater 21(23):300–308 (discussion 308-9)CrossRef
33.
go back to reference Chow WY, Taylor AM, Reid DG et al (2011) Collagen atomic scale molecular disorder in ochronotic cartilage from an alkaptonuria patient, observed by solid state NMR. J Inherit Metab Dis Dec;34(6):1137–1140CrossRefPubMed Chow WY, Taylor AM, Reid DG et al (2011) Collagen atomic scale molecular disorder in ochronotic cartilage from an alkaptonuria patient, observed by solid state NMR. J Inherit Metab Dis Dec;34(6):1137–1140CrossRefPubMed
34.
go back to reference Taylor AM, Boyde A, Wilson PJ et al (2011) The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 63(12):3887–3896. doi:10.1002/art.30606 CrossRefPubMed Taylor AM, Boyde A, Wilson PJ et al (2011) The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 63(12):3887–3896. doi:10.​1002/​art.​30606 CrossRefPubMed
39.
40.
go back to reference Jebaraj I, Rao A. (2006) Achilles tendon enthesopathy in ochronosis. J Postgrad Med 52(1):47–8PubMed Jebaraj I, Rao A. (2006) Achilles tendon enthesopathy in ochronosis. J Postgrad Med 52(1):47–8PubMed
42.
go back to reference Kumar RVM, Rajasekaran S. (2003) Spontaneous tendon ruptures in alkaptonuria. J Bone Joint Surg 85(6):883–6 Kumar RVM, Rajasekaran S. (2003) Spontaneous tendon ruptures in alkaptonuria. J Bone Joint Surg 85(6):883–6
44.
go back to reference Hachulla E, Janin A, Flipo RM et al (1993) Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum 36:691–697. doi:10.1002/art.1780360518 CrossRefPubMed Hachulla E, Janin A, Flipo RM et al (1993) Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum 36:691–697. doi:10.​1002/​art.​1780360518 CrossRefPubMed
45.
go back to reference Taylor AM, Wilson PJ, Ingrams DR et al (2010) Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria. J Clin Pathol 63(2):186–188CrossRefPubMed Taylor AM, Wilson PJ, Ingrams DR et al (2010) Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria. J Clin Pathol 63(2):186–188CrossRefPubMed
Metadata
Title
Histological and Ultrastructural Characterization of Alkaptonuric Tissues
Authors
Lia Millucci
Giulia Bernardini
Adriano Spreafico
Maurizio Orlandini
Daniela Braconi
Marcella Laschi
Michela Geminiani
Pietro Lupetti
Giovanna Giorgetti
Cecilia Viti
Bruno Frediani
Barbara Marzocchi
Annalisa Santucci
Publication date
01-07-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 1/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0260-9

Other articles of this Issue 1/2017

Calcified Tissue International 1/2017 Go to the issue